The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SWOG S2012: Randomized phase II/III trial of first line platinum/etoposide (P/E) with or without atezolizumab (NSC#783608) in patients (pts) with poorly differentiated extrapulmonary small cell neuroendocrine carcinomas (NEC).
 
David Bing Zhen
Consulting or Advisory Role - QED Therapeutics
Research Funding - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Merck; Seagen
 
Edward Mayerson
No Relationships to Disclose
 
E. Gabriela Chiorean
Consulting or Advisory Role - Axiom Healthcare Strategies; Bayer; BioNTech; Cardiff Oncology; Foundation Medicine; G1 Therapeutics; Ipsen; Merck; Novartis; Noxxon Pharma; Noxxon Pharma; Pfizer; Stemline Therapeutics
Research Funding - AADi (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); FibroGen (Inst); Halozyme (Inst); Lonza (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Stemline Therapeutics (Inst)
 
Earle F Burgess
Stock and Other Ownership Interests - Arvinas; Autolus; Becton Dickinson; Calithera Biosciences; Exelixis; Gilead Sciences; Macrogenics; Medtronic
Honoraria - Exelixis; Janssen Oncology; Merck; Novartis; Pfizer
Consulting or Advisory Role - Johnson & Johnson
Speakers' Bureau - AstraZeneca; Exelixis
Research Funding - Astellas Pharma; Pfizer
 
Elizabeth M. Swisher
Leadership - IDEAYA Biosciences
 
Carl Michael Gay
No Relationships to Disclose
 
Lauren Averett Byers
Consulting or Advisory Role - Abbvie; Alethia Biotherapeutics; AstraZeneca; Bristol-Myers Squibb; Debiopharm Group; Genentech; Genmab; Jazz Pharmaceuticals; Merck; Pfizer; PharmaMar; Sierra Oncology; Tolero Pharmaceuticals
Research Funding - AstraZeneca (Inst); Genmab (Inst); Sierra Oncology; Tolero Pharmaceuticals
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Asuragen; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Lilly; Flame Biosciences; Flame Biosciences; Genentech/Roche; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; Merck; MSD Oncology; Novartis; OncoCyte; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Merck; MSD Oncology; Pfizer; Roche
Research Funding - 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Adaptive Biotechnologies (Inst); Akoya Biosciences (Inst); Amgen (Inst); Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); Iovance Biotherapeutics (Inst); Johnson & Johnson (Inst); Karus Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Takeda (Inst)
 
Haider Mahdi
Research Funding - Puma Biotechnology; Puma Biotechnology
 
Satya Das
Honoraria - Ipsen; Novartis; Tersera
Research Funding - Exelixis
 
Jason S. Starr
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Natera; Pfizer; Taiho Oncology; Tersera
Research Funding - Incyte (Inst); Leap Therapeutics; Macrogenics (Inst); Merus (Inst); Molecular Templates (Inst); Rafael Pharmaceuticals (Inst); Vedanta Biosciences (Inst)
 
Megan Othus
Consulting or Advisory Role - Biosight; Cascadia Labs; Daiichi Sankyo; Glycomimetics; Merck
Other Relationship - Celgene; Glycomimetics
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Counsyl; Foundation Medicine; Guardant Health; Hanmi; Immuneoncia; Lilly; Lunit; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; G1 Therapeutics; Genentech/Roche; Jazz Pharmaceuticals; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
Travel, Accommodations, Expenses - Hanmi
 
Razelle Kurzrock
No Relationships to Disclose